Form 4: Director D. Keith Grossman Receives Outset Medical RSUs

Director D. Keith Grossman acquired 10,667 restricted stock units in Outset Medical, Inc. as part of an equity grant.

Summary

• Director D. Keith Grossman was granted 10,667 restricted stock units (RSUs) of Outset Medical, Inc. common stock.
• The transaction occurred on June 4, 2026, at a price of $0.0 per share, representing an equity compensation grant.
• Following this transaction, Grossman holds 24,585 shares directly and 12,845 shares indirectly through the Grossman Family Trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.

Positives

• Alignment of director interests with shareholders through equity-based compensation.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

The RSUs are scheduled to vest on the earlier of the one-year anniversary of the grant date or the date of the Issuer's next Annual Meeting of Stockholders.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practice to ensure long-term alignment with shareholder value in the medical device sector.

Comparison to Industry Standards

• The grant of RSUs to directors is consistent with standard compensation practices for publicly traded medical technology companies.
• The vesting schedule tied to the next annual meeting is a common retention and governance mechanism.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity compensation event.

Next Steps

• Vesting of 10,667 RSUs on the earlier of June 4, 2027, or the next Annual Meeting of Stockholders.

Key Dates

Keywords

Outset Medical, OM, Form 4, Insider Trading, Equity Grant, Director Compensation